Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapyMasanori Okaniwa(Takeda (Japan))PLoS ONEOctober 24, 201710.1371/journal.pone.0186587Cited by 23SaveCiteExport RISWatch citationsRelated PapersA Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity|PLoS ONE|2015|34